●
Earnings Feed
Filings
Companies
Insiders
Pricing
Blog
⌘
K
Login
Start Free
$OLMA
|
10-Q
Aug 11, 4:15 PM ET
Olema Pharmaceuticals, Inc. 10-Q
Loading document...
Contents
17
Basis of Presentation and Consolidation
Unaudited Interim Financial Information
Use of Estimates
Cash and Cash Equivalents
Marketable Securities
Concentration of Credit Risk and Other Risks and Uncertainties
Leases
Research and Development Costs
Research Contract Costs and Accruals
Internal-Use Software
Comprehensive Loss
Stock-Based Compensation
Foreign Currency Transactions
Pre-funded Warrants
Net Loss Per Common Share
Segment Reporting
Recent Accounting Pronouncements Not Yet Adopted